Company intelligence / Profile preview

Kamosys

Neutal, Burgenland, Austriakamosys.eu ↗

Ownership: Private
Development stage: Other

Overview

Kamosys specializes in biosimilars and personalized medicine by providing validated digital tools such as Digital Twins for cell culture optimization and cGMP-compliant software solutions. Their platforms support GxP environments with robust data/document management systems tailored to the needs of pharma/biotech companies. They also offer GMP batch certification services for clinical/commercial product release

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Kamosys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kamosys.

Explore the full profile